Movement Alert｜10x Genomics, Inc. Rises 5.59% in Regular Trading, RBC Initiates Coverage With $70 Price Target

Market Focus09-02

On September 2, 10x Genomics, Inc. rose 5.59% in regular trading, trading at $62.66 per share, with turnover of $9.93 million. The rally was driven by RBC Capital Markets initiating coverage of the company with a $70 price target, significantly above the FactSet analyst consensus target of $51.

RBC assigned a Sector Perform rating, highlighting 10x Genomics, Inc.'s leadership in high-plex spatial molecular profiling with over 60% market share. The bank noted that the spatial business remains in early-stage adoption and continues to deliver double-digit growth, even ahead of the upcoming Atera product launch. However, RBC flagged the single-cell segment as a structural growth headwind, with double-digit price-per-reaction declines offsetting volume gains. RBC emphasized that the company needs to achieve meaningful growth in its single-cell franchise to unlock further valuation upside.

Recent developments also provide context: Q2 results reported in early August showed EPS of -$0.14, beating the -$0.24 estimate, while revenue of $151 million topped expectations. Full-year guidance was raised to $610-$630 million.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146845141?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-02 21:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146845141","market":"hk","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Rises 5.59% in Regular Trading, RBC Initiates Coverage With $70 Price Target","media":"Market Focus","content":"<p><p>On September 2, 10x Genomics, Inc. rose 5.59% in regular trading, trading at $62.66 per share, with turnover of $9.93 million. The rally was driven by RBC Capital Markets initiating coverage of the company with a $70 price target, significantly above the FactSet analyst consensus target of $51.</p><p>RBC assigned a Sector Perform rating, highlighting 10x Genomics, Inc.'s leadership in high-plex spatial molecular profiling with over 60% market share. The bank noted that the spatial business remains in early-stage adoption and continues to deliver double-digit growth, even ahead of the upcoming Atera product launch. However, RBC flagged the single-cell segment as a structural growth headwind, with double-digit price-per-reaction declines offsetting volume gains. RBC emphasized that the company needs to achieve meaningful growth in its single-cell franchise to unlock further valuation upside.</p><p>Recent developments also provide context: Q2 results reported in early August showed EPS of -$0.14, beating the -$0.24 estimate, while revenue of $151 million topped expectations. Full-year guidance was raised to $610-$630 million.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Rises 5.59% in Regular Trading, RBC Initiates Coverage With $70 Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Rises 5.59% in Regular Trading, RBC Initiates Coverage With $70 Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-02 21:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 2, 10x Genomics, Inc. rose 5.59% in regular trading, trading at $62.66 per share, with turnover of $9.93 million. The rally was driven by RBC Capital Markets initiating coverage of the company with a $70 price target, significantly above the FactSet analyst consensus target of $51.</p><p>RBC assigned a Sector Perform rating, highlighting 10x Genomics, Inc.'s leadership in high-plex spatial molecular profiling with over 60% market share. The bank noted that the spatial business remains in early-stage adoption and continues to deliver double-digit growth, even ahead of the upcoming Atera product launch. However, RBC flagged the single-cell segment as a structural growth headwind, with double-digit price-per-reaction declines offsetting volume gains. RBC emphasized that the company needs to achieve meaningful growth in its single-cell franchise to unlock further valuation upside.</p><p>Recent developments also provide context: Q2 results reported in early August showed EPS of -$0.14, beating the -$0.24 estimate, while revenue of $151 million topped expectations. Full-year guidance was raised to $610-$630 million.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1146845141","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146845141","pubTimestamp":1788357111,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 2, 10x Genomics, Inc. rose 5.59% in regular trading, trading at $62.66 per share, with turnover of $9.93 million. The rally was driven by RBC Capital Markets initiating coverage of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易上涨 5.59%，加拿大皇家银行启动覆盖，目标价为 70 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On September 2, 10x Genomics, Inc. rose 5.59% in regular trading, trading at $62.66 per share, with turnover of $9.93 million. The rally was driven by RBC Capital Markets initiating coverage of the company with a $70 price target, significantly above the FactSet analyst consensus target of $51.RBC assigned a Sector Perform rating, highlighting 10x Genomics, Inc.'s leadership in high-plex spatial molecular profiling with over 60% market share. The bank noted that the spatial business remains in early-stage adoption and continues to deliver double-digit growth, even ahead of the upcoming Atera product launch. However, RBC flagged the single-cell segment as a structural growth headwind, with double-digit price-per-reaction declines offsetting volume gains. RBC emphasized that the company needs to achieve meaningful growth in its single-cell franchise to unlock further valuation upside.Recent developments also provide context: Q2 results reported in early August showed EPS of -$0.14, beating the -$0.24 estimate, while revenue of $151 million topped expectations. Full-year guidance was raised to $610-$630 million.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146845141","isCrawlerRequest":true}